Evaluation of Surfactant Replacement Therapy Effects--A New Potential Role of Lung Ultrasound

Srp Arh Celok Lek. 2015 Nov-Dec;143(11-12):669-75. doi: 10.2298/sarh1512669l.

Abstract

Introduction: Previous studies suggested that effects of the surfactant administration in preterm intants with respiratory distress syndrome cannot be followed by lung ultrasound (L-US).

Objective: The aim of the paper is to evaluate the surfactant replacement therapy effects using a new, proposed grading system for L-US findings.

Methods: We report the series of 12 preterm infants with clinical and radiographic signs of respiratory distress syndrome, in whom L-US examinations were performed prior to, and within the first 24 hours after surfactant administration. To evaluate the surfactant replacement therapy effects, we proposed a new grading system (1 to 6) for L-US findings at each examined lung area, based on the presence of normal finding, the amount of B-lines and subpleural consolidations.

Results: All preterm infants had an improvement of L-US findings from one to four grades observed within the first 24 hours after surfactant administration, which has not been previously reported. The improvement of L-US findings was most commonly observed in anterior lung areas.

Conclusion: L-US might enable an early detection of the surfactant replacement therapy effects. Further prospective studies are necessary to define the role of L-US in this field.

MeSH terms

  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Male
  • Prospective Studies
  • Pulmonary Surfactants / therapeutic use*
  • Respiratory Distress Syndrome, Newborn / diagnostic imaging*
  • Respiratory Distress Syndrome, Newborn / therapy*
  • Treatment Outcome
  • Ultrasonography

Substances

  • Pulmonary Surfactants